NFKB1 and neoplasm: This is frequently associated with a loss of sensitivity to anti-proliferative TGF-β and/or inhibin-mediated activity, reduced NF-kB-mediated control of inflammation and immune response, in addition to increased cell migration and invasion, angiogenesis, and tumor progression along with reduced apoptosis [17,18,19,28,58,62].